S. Charles Schulz, MD

Supplement Article

Assessing Cognitive Impairment in Patients With Schizophrenia

February 24, 2016

Supplement Article

Behavioral and Emerging Pharmacologic Treatment Options for Cognitive Impairment in Schizophrenia

February 24, 2016

Original Research

A Dose Comparison of Olanzapine for the Treatment of Borderline Personality Disorder: A 12-Week Randomized, Double-Blind, Placebo-Controlled Study

April 5, 2011

Original Research

Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Acute Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study

June 15, 2007

Article

Clinical Use of Quetiapine in Disease States Other Than Schizophrenia

December 31, 2002

Original Research

Lithium Augmentation Fails to Reduce Symptoms in Poorly Responsive Schizophrenic Outpatients

June 30, 1999

Article

Treatment and Outcomes in Adolescents With Schizophrenia

June 1, 1998